Prescription Drug Advertising and Promotion: Learnings from Recent Food and Drug Administration Warning Letters

2007 ◽  
Vol 41 (3) ◽  
pp. 281-289 ◽  
Author(s):  
Eric B. Benson ◽  
Sherman N. Alfors
1992 ◽  
Vol 22 (2) ◽  
pp. 265-276 ◽  
Author(s):  
Marianne R. Watts ◽  
Judith D. Wilkenfeld

The article focuses on the manner in which the Federal Trade Commission regulates advertising in general and over-the-counter drug advertising in particular. It also highlights the cooperation that exists between the Commission and the Food and Drug Administration in both food and drug matters.


1999 ◽  
Vol 25 (1) ◽  
pp. 149-167
Author(s):  
Tamar V. Terzian

The Food and Drug Administration (FDA) regulates the promotion of pharmaceutical products. The FDA's regulations issued under the Food, Drug and Cosmetic Act (FDCA) require that prescription drug broadcast advertisements include the following: (1) a major statement of the product's risks in at least the audio part of the advertisement; and (2) that an adequate provision for the dissemination of the approved package labeling be made “in connection with the broadcast presentation,” if the brief summary is not also part of the advertisement. Under the FDCA, the brief summary provides information concerning the major risks of the drug.


Sign in / Sign up

Export Citation Format

Share Document